Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-951-9 | CAS number: 101-54-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: limitations in documentation and study design (e.g. only one sex is treated; only the 4-ADPA concentration in the diet is given); acceptable for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- Acute and short-term toxicity studies on p-aminodiphenylamine.
- Author:
- Singh RL, Khanna SK, Shanker R, Singh GB
- Year:
- 1 986
- Bibliographic source:
- Vet Hum Toxicol 28: 219 - 223
Materials and methods
- Principles of method if other than guideline:
- Method: other subchronic toxicity study
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- N-(4-aminophenyl)aniline
- EC Number:
- 202-951-9
- EC Name:
- N-(4-aminophenyl)aniline
- Cas Number:
- 101-54-2
- Molecular formula:
- C12H12N2
- IUPAC Name:
- N1-phenylbenzene-1,4-diamine
- Details on test material:
- IUCLID4 Test substance: other TS: commercial grade from Koch-Light Laboratories Ltd.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- other: 4-ADPA contained in diet
- Duration of treatment / exposure:
- 90 d
- Frequency of treatment:
- continuously in diet
Doses / concentrations
- Remarks:
- Doses / Concentrations:
1,000, 2,500, 5,000, 7,500 ppm (approximately 100, 250, 500 and 750 mg/kg bw/day)
Basis:
nominal in diet
- No. of animals per sex per dose:
- 12 males
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- Post-exposure period: no
Results and discussion
Effect levels
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 100 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- other: erythrocyte sedimentation rate increased, no other effects
- Dose descriptor:
- LOAEL
- Effect level:
- 250 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- other: haematological changes, changes in liver enzymes
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
RS-Freetext:
TOXIC RESPONSE/EFFECTS BY DOSE LEVEL:
- Mortality and time to death: no information relating to mortality reported
- Clinical signs: not reported
- Body weight gain: reduction at higher dose; overall
weight gain 11.7 % at 5,000 ppm, 0 % at 7,500 ppm in
comparison to 36 % in controls (no further details)
- Food consumption: reduction from 10th week onward until
end of study: The average reduction in the last 4 weeks was documented to
be -13 % at 5,000 ppm, -26 % at 7,500 ppm; no
effect for lower dosages
- Clinical chemistry:
Serum: from 2,500 ppm GOT and GPT significantly increased
(p<= 0.01); from 5,000 ppm acid and alkaline phosphatase
significantly increased (p<= 0.01); at 2,500 and 5,000 ppm
cholesterol significantly increased (p<= 0.01)
Liver: from 5000 ppm dose-dependent decrease of acid and
alkaline phosphatase which became statistically significant (p <= 0.05)
at 7500 ppm, at 7500 ppm esterified cholesterol significantly decreased
(p <= 0.05) but no pronounced change in the total cholesterol
Testis: marginal depletion of 25% for of LDH and hyaluronidase at 5000 and 7500ppm;
from 5,000 ppm significant effect for hyaluronidase (p<0.05)
Accessory sex organs: Alkaline phosphatase of seminal vesicles, acid
phosphatase in ventral prostates, and fructose in coagulating glands and
dorso-lateral prostates did not reveal any consistent change over matched
controls
-Haematology: statistically significant increase in erythrocyte
at 1000 ppm: erythrocytes sedimentation rate increased
sedimention rate and MCH at 2500 and 7500 ppm; from 2,500 ppm RBC and Hb
significantly decreased and MCV significantly increased (p<0.01); at
7,500 ppm packed cellular volume (hematocrit)
significantly decreased (p<0.01)
-Organ weights: Average relative organ weights of heart, lung, spleen,
testis and kidney remained unaffected; an increase of about +35 % both at
5,000 ppm and 7500 ppm is described for the liver
- Histopathology:
Liver: from 5,000 ppm degenerative changes of hepatocytes,
plasma cell reaction in portal triad areas; normal
appearance at lower dosages
Testis: 7,500 ppm patchy degeneration of seminiferous
tubules, no multinucleated giant cells,
interstitial tissue had normal vascularity and Leydig cells; no damage at
lower dosages
Applicant's summary and conclusion
- Conclusions:
- CL-Freetext:
No effects were observed at 1000 ppm. Body weight retardation parallel to reduced food intake was observed from 5,000 ppm onwards.
The haematological changes observed from 2500 ppm onwards suggest anemia. Hepatotoxicity is evident
from increased liver weight (>= 5000 ppm), changes in marker enzymes in the serum (>= 2500 ppm) and histopathological changes (>= 5000 ppm). Decreased hyaluronidase in testis (>= 5000 ppm) and degeneration of seminiferous tubules (7500 ppm) were observed at dose levels which are in the magnitude of the acute LD50-value (7500 ppm correspond to 555-750 mg/kg bw/day). - Executive summary:
In a 90-day study, groups of 12 male Wistar rats were orally exposed to dietary concentrations of 1000, 2500, 5000 or 7500 ppm 4-ADPA (approximately 100, 250, 500 (435), 750 (555) mg/kg bw/d). No information is given with regard to mortality and clinical signs. For these two highest doses only a decrease in body weight gain (11.7% at 5000 ppm, 0% at 7500 ppm in comparison to 36% in controls) in parallel to a reduced food intake was described (decrease of 13% at 5000 ppm and 26% at 7500 ppm corresponding to calculated doses approximately 435 and 555 mg/kg bw/day). Haematological changes observed at =2500 ppm (approximately 250 mg/kg bw/d; reduction of erythrocytes and haemoglobin, increased MCV) suggest anaemia. Unchanged organ weights and no findings in microscopic examination of heart, lung, spleen, adrenals and kidneys as well as unchanged accessory sex gland weight revealed no adverse effects to these organs. Hepatotoxicity was evident from increased liver weight (35% both at 5000 and 7500 ppm) and changes in marker enzymes in serum at =2500 ppm (approximately 250 mg/kg bw/d). Histopathological findings as degenerative changes of hepatocytes from 5000 ppm (approximately 435-500 mg/kg bw/d) and plasma cell reaction in portal triad area also showed a hepatotoxic effect of 4-ADPA, whereas the livers presented normal appearance at doses of 2500 ppm and lower. At 7500 ppm (approximately 555-750 mg/kg bw/d) degeneration of seminiferous tubules in testes as well as decreased hyaluronidase activity in testes which started at 5000 ppm (approximately 435 ¿ 500 mg/kg bw/d) were described. There were no multinucleated cells and interstitial tissue had normal vascularity and Leydig cells. No histological damage was seen at lower doses and testes weight was unaffected over the whole dose range (Singh 1986). For the 90-day feeding of 4-ADPA to male rats a NOAEL of 1000 ppm, corresponding to a dose of approximately 100 mg/kg bw/d is derived with regard to haematology parameters and changes in liver enzymes as first indication of an impact on this organ (Singh 1986).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.